Dynavax (NASDAQ: DVAX) reported Q2 EPS of ($0.63), in-line with the analyst estimate of ($0.63). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.62 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.